Dyne Therapeutics (NASDAQ:DYN) hits new 52-week high after better-than-expected earnings
Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) shares reached a new 52-week high on Monday following a stronger-than-expected earnings report. The stock traded as high as $45.56 and was last…